| 產(chǎn)品名稱 | PD 166793 |
| 產(chǎn)品貨號(hào) | Axon 1271 CAS [199850-67-4] MF C17H18BrNO4SMW 412.30 Purity: 99% Optical purity: >98% ee Soluble in 0.1N NaOH(aq), DMSO, and Ethanol Description Matrix metalloproteinase (MMP) inhibitor References Certificates Categories Extra info H León et al. Inhibition of matrix metalloproteinases prevents peroxynitrite-induced contractile dysfunction in the isolated cardiac myocyte. Br. J. Pharmacol. 2008, 153(4), 676-683. ? MM Sung et al. Matrix metalloproteinase-2 degrades the cytoskeletal protein α-actinin in peroxynitrite mediated myocardial injury. J. Mol. Cel. Cardiol. 2007, 43(4), 429-436. ? AL Chancey et al. Effects of Matrix Metalloproteinase Inhibition on Ventricular Remodeling Due to Volume Overload. Circulation 2002, 105, 1983-1988. Certificate of Analysis Material Safety Data Sheet Angiogenesis Cell Signaling & Oncology Miscellaneous Pain & Inflammation EC 3.4.24.24 MMP MMP inhibitor Chemical name (S)-2-(4'-Bromo-biphenyl-4-sulfonylamino)-3-methyl-butyric acid Parent CAS No. [199850-67-4] Order Size Unit Price Stock 10 mg €90.00 In Stock |
| 產(chǎn)品價(jià)格 | 現(xiàn)貨詢價(jià)，電話：010-67529703 |
| 產(chǎn)品規(guī)格 | |
| 產(chǎn)品品牌 | axonmedchem |
| 產(chǎn)品概述 | |
| 產(chǎn)品詳情 |
PD 166793Axon 1271 CAS [199850-67-4] MF C17H18BrNO4S
Description
Matrix metalloproteinase (MMP) inhibitor
MMP inhibitor
Chemical name(S)-2-(4'-Bromo-biphenyl-4-sulfonylamino)-3-methyl-butyric acid Parent CAS No.[199850-67-4] |
| 產(chǎn)品資料 |
